These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3514494

  • 1. Treatment of claudication with dipyridamole and aspirin.
    Libretti A, Catalano M.
    Int J Clin Pharmacol Res; 1986; 6(1):59-60. PubMed ID: 3514494
    [Abstract] [Full Text] [Related]

  • 2. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J, Wouda AA, Kallenberg CG, Wesseling H.
    Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of claudication with dipyridamole and aspirin.
    Libretti A, Catalano M.
    Monogr Atheroscler; 1986; 14():207-9. PubMed ID: 3526127
    [No Abstract] [Full Text] [Related]

  • 4. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM, Salter MC, Donaldson DR, Subba Rao R, Boyle RM, Partridge JB, Watson DA.
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [Abstract] [Full Text] [Related]

  • 5. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
    Statham B, Finlay AY, Marks R.
    Acta Derm Venereol; 1981 Sep; 61(3):270-1. PubMed ID: 6167117
    [Abstract] [Full Text] [Related]

  • 6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Forbes CD.
    Int J Clin Pract; 1997 Jun; 51(4):205-8. PubMed ID: 9287258
    [Abstract] [Full Text] [Related]

  • 10. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV, Khuri SF, Josa M, Folland ED, Parisi AF.
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [Abstract] [Full Text] [Related]

  • 11. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 12. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
    Circulation; 1980 Dec 15; 62(6 Pt 2):V85-8. PubMed ID: 7002354
    [Abstract] [Full Text] [Related]

  • 13. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov 15; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 14. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, Olsson JE, Olsson O, Thornberg A.
    Lakartidningen; 1980 Dec 24; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication.
    Gresele P, Migliacci R, Procacci A, De Monte P, Bonizzoni E.
    Thromb Haemost; 2007 Mar 24; 97(3):444-50. PubMed ID: 17334512
    [Abstract] [Full Text] [Related]

  • 17. Three large-scale clinical trials of aspirin in the USA.
    Krol WF.
    Proc R Soc Med; 1977 Mar 24; 70 Suppl 7(Suppl 7):24-7. PubMed ID: 353816
    [No Abstract] [Full Text] [Related]

  • 18. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 19. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
    Illnait J, Castaño G, Alvarez E, Fernández L, Mas R, Mendoza S, Gamez R.
    Angiology; 2008 Jan 27; 59(3):269-77. PubMed ID: 18388038
    [Abstract] [Full Text] [Related]

  • 20. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
    Fortschr Med; 1980 Aug 28; 98(32):1227-8. PubMed ID: 7409723
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.